Article
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration
2021-02-09
Abstract excerpt
The dramatically expanding COVID-19 needs multiple effective countermeasures. Neutralizing antibodies are a potential therapeutic strategy for treating COVID-19. A number of neutralizing nanobodies (Nbs) were reported for their in vitro activities. However, in vivo protection of these nanobodies was not reported in animal models. In the current report, we characterized several RBD-specific Nbs isolated from a sc...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9b6d64e6-ea28-589f-9509-d58e8c3bb5f7
- DOI
- 10.1101/2021.02.08.429275
